Nikola Subject, a guard for the NBA’s Oklahoma Metropolis Thunder, is present process chemotherapy therapy for testicular most cancers, staff leaders introduced Thursday.
Subject, 20, underwent a biopsy in Houston to diagnose the issue earlier in October, in accordance with the Thunder. Common supervisor Sam Presti stated Subject requested the staff to not disclose his prognosis till he started therapy.
“Our only expectations for him are to focus on this,” Presti stated at a press convention. “This is his most important priority. He’ll be back playing basketball when he’s able to, but we’re not putting any time length or expectations on that, obviously. He has our total support, encouragement and love.”
Subject, a Serbian native, was chosen by the Thunder with the twelfth choose within the 2024 NBA Draft however missed the entire 2024-25 season with an ACL harm whereas his teammates gained the franchise’s first title in Oklahoma Metropolis.
Coming into the season, he was anticipated to offer a scoring increase off the bench for a Thunder squad battling a number of accidents.
“He has all the tools that you could ask for somebody to take on and conquer the situation,” Presti stated Thursday.
Practically 10,000 individuals within the U.S. have been identified with testicular most cancers in 2025, and the five-year survival fee amongst individuals identified with localized testicular most cancers is 99%, in accordance with the American Most cancers Society.
